Literature DB >> 11448088

Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'.

P M Haddad1, S Devarajan, S M Dursun.   

Abstract

We report two patients who developed a severe discontinuation (withdrawal) reaction following stoppage of paroxetine and venlafaxine, respectively. Neurological symptoms were prominent and neither patient could walk unaided. Both patients feared they had suffered a 'stroke' and arranged an emergency medical consultation. One patient was correctly diagnosed, the antidepressant was recommenced and symptoms resolved within 24 h. Failure to recognize the reaction resulted in the other patient being referred to a neurologist, undergoing a computed tomography brain scan and an electroencephalogram and remaining symptomatic for over 8 weeks. Relevant pharmacological issues are discussed. The cases illustrate the importance of patients and clinicians being familiar with antidepressant discontinuation symptoms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448088     DOI: 10.1177/026988110101500210

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  8 in total

1.  A case of interdose discontinuation symptoms with venlafaxine extended release.

Authors:  Joseph Petit; Randy A Sansone
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 2.  Venlafaxine and serious withdrawal symptoms: warning to drivers.

Authors:  Daniel M Campagne
Journal:  MedGenMed       Date:  2005-07-06

3.  Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.

Authors:  E C G van Geffen; J G Hugtenburg; E R Heerdink; R P van Hulten; A C G Egberts
Journal:  Eur J Clin Pharmacol       Date:  2005-05-20       Impact factor: 2.953

4.  The 'patient voice': patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition.

Authors:  Anne Guy; Marion Brown; Stevie Lewis; Mark Horowitz
Journal:  Ther Adv Psychopharmacol       Date:  2020-11-09

Review 5.  Antidepressant discontinuation syndromes.

Authors:  P M Haddad
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

6.  Extended course of repetitive trans-cranial magnetic stimulation therapy and a complicated case of obsessive-compulsive disorder.

Authors:  Ram Jeevan Bishnoi; Venu Gopal Jhanwar
Journal:  Indian J Psychol Med       Date:  2011-01

7.  Withdrawal Symptoms Following Discontinuation of Vortioxetine-Retrospective Chart Review.

Authors:  Marcin Siwek; Adrian Andrzej Chrobak; Aleksandra Gorostowicz; Anna Julia Krupa; Dominika Dudek
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-11

8.  Venlafaxine extended release (XR) in the treatment of panic disorder.

Authors:  Kevin Kjernisted; Diane McIntosh
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.